Company Overview

Novanta Inc. is a U.S.-based industrial technology company that designs and manufactures highly engineered components and subsystems used in precision applications. The company operates primarily in the medical and life sciences, industrial automation, advanced manufacturing, and semiconductor industries, supplying mission‑critical technologies that are embedded into customers’ end products and production systems.

The company’s core revenue drivers are its Precision Motion, Vision, and Photonics technology platforms, which deliver motion control, optical sensing, imaging, and laser-based solutions. Novanta is positioned as a specialized, high‑value supplier with deep engineering expertise, long product life cycles, and high switching costs for customers. Founded in 1968 and originally known as GSI Group, the company rebranded as Novanta Inc. in 2016 following a strategic transformation toward focused, higher‑margin precision technology markets.

Business Operations

Novanta generates revenue through the design, manufacture, and sale of proprietary components, modules, and subsystems that are integrated into customer equipment. Its operating structure centers on three primary business segments: Precision Motion, Vision, and Photonics, each serving OEM customers that require accuracy, reliability, and performance in regulated or high‑precision environments.

Operations span both domestic and international markets, with engineering, manufacturing, and service capabilities distributed across North America, Europe, and Asia. The company controls a portfolio of specialized technologies through subsidiaries such as Celera Motion, ATI Industrial Automation, JADAK, Cambridge Technology, and Synrad, which collectively contribute to Novanta’s vertically integrated design and manufacturing model.

Strategic Position & Investments

Novanta’s strategy emphasizes organic growth through innovation, expansion in high‑growth medical and automation markets, and disciplined acquisitions that strengthen its technology platforms. The company consistently invests in research and development to support emerging applications in robotics‑assisted surgery, diagnostic instrumentation, semiconductor manufacturing, and factory automation.

Strategic acquisitions, including ATI Industrial Automation and other bolt‑on technology companies, have expanded Novanta’s motion control and automation capabilities while increasing exposure to long‑term secular growth trends. The company continues to focus on scalable platforms, operational efficiency, and cross‑selling opportunities across its portfolio of precision technologies.

Geographic Footprint

Novanta is headquartered in North America, with its corporate headquarters located in the United States. The company maintains a significant operational presence across Europe and Asia, supporting global OEM customers with localized engineering, manufacturing, and customer support.

Its global footprint enables Novanta to serve multinational customers in regulated medical markets and high‑volume industrial applications. International operations play a meaningful role in revenue generation, with sales distributed across the Americas, EMEA, and Asia‑Pacific regions, reflecting the company’s broad global market reach.

Leadership & Governance

Novanta is led by an executive team with experience in industrial technology, medical devices, and operational transformation. Leadership emphasizes disciplined capital allocation, technology differentiation, and long‑term value creation through precision engineering and customer partnership.

Key executives include:

• Matthias Stettler – President and Chief Executive Officer
• Robert Buckley – Chief Financial Officer

The leadership team’s strategic vision centers on building a focused portfolio of high‑performance technologies while maintaining strong governance practices and alignment with shareholder interests.